A Morgan Stanley-led arranger group is out with price talk on the $2.95 billion first-lien and $925 million second-lien covenant-lite term loans for Kaseya, Inc. that will be used to refinance existing private credit debt and a portion of preferred equity, according to sources. Commitments to the deal are due by 5 p.m. ET on Thursday, March 6.
Price talk for the seven-year first-lien term loan is S+325-350, with a 0% floor and an OID of 99.5. That implies a yield to maturity of around 7.90%-8.17%. Also, there is a margin step-down of 25 bps at 0.5x inside closing first-lien net leverage, and a 25 bps step-down upon an IPO. Lenders are offered six months of 101 soft call protection.
The eight-year second-lien term loan is talked at S+525, with a 0% floor and an OID of 99.5. At talk, the yield to maturity is around 10.03%. Pricing includes a 25 bps IPO step-down. There are hard calls at 102 and 101 in years 1-2, respectively.
Thus far, S&P Global Ratings has assigned a facility rating of B and a recovery rating of 3 to the first-lien facility. The second-lien loan is rated CCC+, with a recovery rating of 6. The issuer is rated B, and the outlook is stable.
In addition to its term loans, Kaseya will have a new $535 million five-year revolving credit facility with a springing first-lien net leverage covenant.
Kaseya’s existing debt dates to its 2022 acquisition of Datto, which was backed by a financing commitment comprising a $3.3 billion term loan facility, a $200 million delayed-draw term loan, and a $200 million revolver. The financing was provided by a group of private credit firms. Golub Capital Markets was the administrative agent. As of Dec. 31, pricing for the first-lien term loan due June 2029 was S+550 with a 0.75% floor, lender filings show. The take-private acquisition of Datto valued the company at $6.2 billion.
Kaseya, a portfolio company of Insight Partners since 2013, provides IT and security management software for managed service providers (MSPs) and mid-market enterprises (MME).
Featured image: Yuichiro Chino/Getty Images
Learn about our editorial standards.